Today's Stock News: Latest Updates on Public Companies

At a glance

On September 28, 2026, AMD agreed to acquire World Labs in an all-stock transaction valued at approximately $8.2 billion; Kodiak Sciences said Zenkuda and tabirafusp-ted met primary endpoints in the Phase 3 DAYBREAK wet AMD trial; Merck closed an exclusive license for SPR2015 with a $400 million upfront; Snowflake proposed a $3.5 billion convertible note placement.

Drug trials and approvals

Kodiak Sciences (KOD) reported that Zenkuda and tabirafusp-ted met primary vision endpoints in the Phase 3 DAYBREAK wet AMD trial, with Zenkuda’s primary endpoint p=0.0007 and 54% of Zenkuda patients reaching a six-month dosing interval under strict retreatment criteria.

Mirum Pharmaceuticals (MIRM) reported that brelovitug met the Phase 3 AZURE-1 primary endpoint in chronic hepatitis delta at Week 24, with response rates of 56% on 300 mg weekly and 45% on 900 mg every four weeks versus 0% with delayed treatment (p<0.0001).

Tempus AI (TEM) announced FDA 510(k) clearance for its ECG-MR software to flag signs associated with undiagnosed moderate or severe mitral regurgitation for clinical ECGs in patients aged 65 or older at healthcare facilities.

Armlogi Holding (BTOC) reported fiscal 2026 revenue of $185.8 million, with warehousing services revenue up 21.9% to $77.1 million and a widened net loss of $20.9 million for the year.

Deals and acquisitions

Advanced Micro Devices (AMD) agreed to acquire World Labs in an all-stock transaction valued at approximately $8.2 billion, expected to close by the end of 2026 subject to regulatory approvals and customary closing conditions.

Lifecore Biomedical (LFCR) agreed to be acquired by Webster Equity Partners for $6.28 per common share in cash, with total consideration valued up to $663.7 million and additional performance-based payments up to $160 million.

BRIXMOR PROPERTY GROUP (BRX) agreed to acquire Slate Grocery REIT in a transaction valuing the REIT at approximately US$2.3 billion, at US$13.00 per unit in cash, expected to close in Q1 2027 subject to approvals.

Quantum eMotion (QNC) agreed to acquire Plurilock Security for approximately C$33.8 million in cash and shares through a court-approved arrangement, implying about C$0.28 per Plurilock share.

Century Casinos (CNTY) entered into a definitive agreement to sell Century Mile and Century Downs racetracks in Alberta to Highfield Investment Group for approximately $16.4 million (CAD 23.2 million).

Financings and offerings

Snowflake (SNOW) announced proposed a private placement of $3.5 billion of 0.00% convertible senior notes comprising $1.3 billion due 2029 and $2.2 billion due 2031, with initial purchasers’ options to buy additional amounts.

Viking Therapeutics (VKTX) closed concurrent upsized offerings of common stock and convertible senior notes, raising approximately $575.0 million in gross proceeds including full exercise of underwriters’ options.

Hut 8 (HUT) closed a $1.07 billion senior secured revolving credit facility with a four-year term and an initial drawn margin of SOFR plus 175 basis points, including a $1.07 billion letter-of-credit sublimit.

Earnings and guidance

Jefferies Financial Group (JEF) reported third-quarter 2026 net revenues of $2.22 billion and net earnings attributable to common shareholders of $261 million, with diluted EPS of $1.08.

Exascale Labs Holdings (XLAB) reported fiscal 2026 revenue of $14.8 million, up 111.3% year over year, gross profit of $2.4 million and a net loss widened to $12.2 million for the year.

Leadership changes

MongoDB (MDB) named Dev Ittycheria interim president and CEO after Chirantan “CJ” Desai stepped down effective immediately; the board has begun a search for a permanent CEO and retained an executive search firm.

Adeia (ADEA) appointed Dipti Vachani chief executive officer and board member effective October 12, 2026, succeeding Paul E. Davis, who will serve as an adviser through the end of 2026.

Circle Internet Group (CRCL) announced a collaboration with Volante Technologies to add USDC payment and settlement workflows to Volante’s platform, enabling clients to test minting, redemption and wallet-to-wallet payments; no deal value was disclosed.

Contracts and government awards

SCYNEXIS (SCYX) was awarded a BARDA contract providing up to approximately $214 million in non-dilutive funding for development of antifungal candidate SCY-247, with an initial base period award of about $18.5 million.

Comstock Resources (CRK) signed a framework agreement memorializing a $1.65 billion Haynesville Shale partnership with SOCAR and anticipates a definitive purchase and sale agreement by October 31, 2026 and closing by year-end 2026.

Silexion Therapeutics (SLXN) reported preclinical SIL204 findings showing dose-dependent KRAS gene silencing in human cancer cells and linked uptake to naturally occurring lipids in carrier-free assays; the company plans to explore systemic subcutaneous delivery.